AC710,
1351522-04-7,
AC 710,
AC-710,
CHEMBL2206278,
N-(4-{[(5-tert-butyl-1,2-oxazol-3-yl)carbamoyl]amino}phenyl)-5-[(1-ethyl-2,2,6,6-tetramethylpiperidin-4-yl)oxy]pyridine-2-carboxamide,
GTPL8095,
SCHEMBL1698753,
EX-A555,
BCP14396,
BDBM50400602,
MFCD25976599,
ZINC95559390,
AC 710;AC-710,
AKOS025147321,
CS-3415,
SB19144,
NCGC00387454-02,
DA-45824,
HY-13493,
N-(4-(3-(5-(tert-butyl)isoxazol-3-yl)ureido)phenyl)-5-((1-ethyl-2,2,6,6-tetramethylpiperidin-4-yl)oxy)picolinamide,
FT-0700174,
J-690140,
N-[4-[[[[5-(1,1-Dimethethylethyl)-3-isoxazolyl]amino]carbonyl]amino]phenyl]-5-[(1-ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-2-pyridinecarboxamide,
D0V4EX,
CSF1R inhibitor (cancer), Ambit Biosciences,
A15933,
CSF1R inhibitor (cancer/autoimmune/inflammatory disease), Ambit Biosciences,
N5-(6-aminohexyl)-N7-benzyl-3-isopropylpyrazolo[1,5-a]pyrimidine-5,7-diamine hydrochloride,